{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:48:53Z","timestamp":1788835733267,"version":"build-2803163510"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.critrevonc.2024.104458","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T16:11:05Z","timestamp":1722096665000},"page":"104458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Clinical, dermatoscopic, histological and molecular predictive factors of distant melanoma metastasis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9306-7295","authenticated-orcid":false,"given":"Konstantinos","family":"Lallas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanassios","family":"Kyrgidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anestis","family":"Chrysostomidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Vakirlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Apalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimilios","family":"Lallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2024.104458_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2019.10.027","article-title":"Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma","volume":"125","author":"Amaral","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104458_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejca.2022.12.021","article-title":"Identification of stage I\/II melanoma patients at high risk for recurrence using a model combining clinicopathologic factors with gene expression profiling (CP-GEP)","volume":"182","author":"Amaral","year":"2023","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104458_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41523-024-00626-6","article-title":"Circulating tumor DNA validity and potential uses in metastatic breast cancer","volume":"10","author":"Amato","year":"2024","journal-title":"npj Breast Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104458_bib4","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.amjsurg.2021.03.028","article-title":"Utility of a 31-gene expression profile for predicting outcomes in patients with primary cutaneous melanoma referred for sentinel node biopsy","volume":"221","author":"Arnot","year":"2021","journal-title":"Am. J. Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104458_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1245\/s10434-019-07830-w","article-title":"The landmark series: MSLT-1, MSLT-2 and DeCOG (Management of Lymph Nodes)","volume":"27","author":"Bello","year":"2020","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104458_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2559.1990.tb00757.x","article-title":"Thin malignant melanomas (less than 1.5 mm) with metastasis: a histological study and survival analysis","volume":"17","author":"Blessing","year":"1990","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2024.104458_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejca.2023.04.010","article-title":"Activity and safety of first-line treatments for advanced melanoma: a network meta-analysis","volume":"188","author":"Boutros","year":"2023","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104458_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00432-012-1322-z","article-title":"A nine-gene signature predicting clinical outcome in cutaneous melanoma","volume":"139","author":"Brunner","year":"2013","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104458_bib9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/jamadermatol.2019.0069","article-title":"Risk factors for lymphatic and hematogenous dissemination in patients with stages I to II cutaneous melanoma","volume":"155","author":"Calomarde-Rees","year":"2019","journal-title":"JAMA Dermatol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104458_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/030089168306900513","article-title":"Metastatic spread of stage I melanoma of the skin","volume":"69","author":"Cascinelli","year":"1983","journal-title":"Tumor J."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104458_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/028418698430412","article-title":"Central nervous system metastases of cutaneous malignant melanoma--a population-based study","volume":"37","author":"Cohn-Cedermark","year":"1998","journal-title":"Acta Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104458_bib12","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ejso.2020.09.028","article-title":"Clinical outcomes following surgical treatment of lentigo maligna of the head and neck","volume":"47","author":"Crouch","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104458_bib13","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1245\/s10434-007-9357-0","article-title":"Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy","volume":"14","author":"Dalal","year":"2007","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104458_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00008390-200504000-00006","article-title":"Increased incidence of brain metastases in cutaneous head and neck melanoma","volume":"15","author":"Daryanani","year":"2005","journal-title":"Melanoma Res."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104458_bib15","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/hed.23718","article-title":"Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy","volume":"37","author":"Davis-Malesevich","year":"2015","journal-title":"Head. Neck"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104458_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174871","article-title":"Dermoscopic characteristics of melanoma according to the criteria \"ulceration\" and \"mitotic rate\" of the AJCC 2009 staging system for melanoma","volume":"12","author":"Deinlein","year":"2017","journal-title":"PLOS One"},{"key":"10.1016\/j.critrevonc.2024.104458_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.19889","article-title":"BAUSSS biomarker further validated as a key risk staging tool for patients with primary melanoma","author":"Dixon","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.critrevonc.2024.104458_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.19772","article-title":"Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients","author":"Dixon","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104458_bib19","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.surg.2015.12.002","article-title":"Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes","volume":"159","author":"Egger","year":"2016","journal-title":"Surgery"},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104458_bib20","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1177\/000313481107700816","article-title":"Lymphovascular invasion as a prognostic factor in melanoma","volume":"77","author":"Egger","year":"2011","journal-title":"Am. Surg."},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104458_bib21","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1245\/s10434-019-07690-4","article-title":"Age and lymphovascular invasion accurately predict sentinel lymph node metastasis in T2 melanoma patients","volume":"26","author":"Egger","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104458_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejca.2020.08.029","article-title":"Identification of stage I\/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model","volume":"140","author":"Eggermont","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104458_bib23","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1200\/JCO.20.02446","article-title":"Development and validation of nomograms to predict local, regional, and distant recurrence in patients with thin (T1) melanomas","volume":"39","author":"El Sharouni","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104458_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/jamadermatol.2020.5032","article-title":"Association of histologic regression with a favorable outcome in patients with stage 1 and stage 2 cutaneous melanoma","volume":"157","author":"El Sharouni","year":"2021","journal-title":"JAMA Dermatol."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104458_bib25","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejso.2022.08.012","article-title":"A cohort analysis of surgically treated primary head and neck lentigo maligna (melanoma): prognostic value of melanoma subtype and new insights in the clinical value of guideline adherence","volume":"49","author":"Elshot","year":"2023","journal-title":"Eur. J. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104458_bib26","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.21873\/anticanres.13024","article-title":"Risk factors for regional and systemic metastases in patients with sentinel lymph node-negative melanoma","volume":"38","author":"Erdmann","year":"2018","journal-title":"Anticancer Res."},{"issue":"23","key":"10.1016\/j.critrevonc.2024.104458_bib27","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104458_bib28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1245\/s10434-016-5566-8","article-title":"Nodular histologic subtype and ulceration are tumor factors associated with high risk of recurrence in sentinel node-negative melanoma patients","volume":"24","author":"Faut","year":"2017","journal-title":"Ann. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104458_bib29","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1245\/s10434-020-08959-9","article-title":"Sentinel node status is the most important prognostic information for clinical stage IIB and IIC melanoma patients","volume":"27","author":"Fonseca","year":"2020","journal-title":"Ann. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104458_bib30","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000499689","article-title":"A retrospective cohort study on patients with lentigo maligna melanoma","volume":"235","author":"Fr\u00f6hlich","year":"2019","journal-title":"Dermatology"},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104458_bib31","doi-asserted-by":"crossref","first-page":"1593806","DOI":"10.1080\/2162402X.2019.1593806","article-title":"Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis","volume":"8","author":"Fu","year":"2019","journal-title":"Oncoimmunology"},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104458_bib32","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1158\/1078-0432.CCR-18-2847","article-title":"Validation of melanoma immune profile (MIP), a prognostic immune gene prediction score for stage II-III melanoma","volume":"25","author":"Gartrell","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104458_bib33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2020.03.053","article-title":"Molecular risk prediction in cutaneous melanoma: a meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients","volume":"83","author":"Greenhaw","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104458_bib34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bjd.15552","article-title":"Prognostic role of histological regression in primary cutaneous melanoma: a systematic review and meta-analysis","volume":"178","author":"Gualano","year":"2018","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104458_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archderm.138.5.603","article-title":"Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases","volume":"138","author":"Guitart","year":"2002","journal-title":"Arch. Dermatol."},{"issue":"21","key":"10.1016\/j.critrevonc.2024.104458_bib36","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1158\/1078-0432.CCR-14-2566","article-title":"A miRNA-based signature detected in primary melanoma tissue predicts development of brain metastasis","volume":"21","author":"Hanniford","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104458_bib37","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archdermatol.2011.44","article-title":"Increases in melanoma among adolescent girls and young women in California: trends by socioeconomic status and UV radiation exposure","volume":"147","author":"Hausauer","year":"2011","journal-title":"Arch. Dermatol."},{"issue":"13","key":"10.1016\/j.critrevonc.2024.104458_bib38","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1200\/JCO.19.01508","article-title":"Cumulative incidence and predictors of CNS metastasis for patients with American joint committee on cancer 8th edition stage III melanoma","volume":"38","author":"Haydu","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104458_bib39","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jfma.2022.02.018","article-title":"Risk factors for lymphatic and hematogenous metastasis after diagnosis of cutaneous melanoma in Taiwan","volume":"121","author":"Hsu","year":"2022","journal-title":"J. Formos. Med Assoc."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104458_bib40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13045-017-0520-1","article-title":"Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test","volume":"10","author":"Hsueh","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104458_bib41","doi-asserted-by":"crossref","DOI":"10.1200\/PO.20.00119","article-title":"Long-term outcomes in a multicenter, prospective cohort evaluating the prognostic 31-gene expression profile for cutaneous melanoma","author":"Hsueh","year":"2021","journal-title":"JCO Precis Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104458_bib42","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1186\/s12885-022-09781-0","article-title":"A population-based validation study of the 8th edition UICC\/AJCC TNM staging system for cutaneous melanoma","volume":"22","author":"Hynes","year":"2022","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104458_bib43","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jaad.2022.06.1202","article-title":"Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test","volume":"87","author":"Jarell","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"36","key":"10.1016\/j.critrevonc.2024.104458_bib44","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.2217\/fon-2021-0996","article-title":"The 31-gene expression profile stratifies recurrence and metastasis risk in patients with cutaneous melanoma","volume":"17","author":"Jarell","year":"2021","journal-title":"Future Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104458_bib45","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/jid.2010.354","article-title":"Gender differences in melanoma survival: female patients have a decreased risk of metastasis","volume":"131","author":"Joosse","year":"2011","journal-title":"J. Investig. Dermatol."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104458_bib46","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1245\/s10434-020-09563-7","article-title":"Evaluation of a gene expression profiling assay in primary cutaneous melanoma","volume":"28","author":"Kangas-Dick","year":"2021","journal-title":"Ann. Surg. Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2024.104458_bib47","first-page":"E754","article-title":"Aberrant lymphatic drainage and risk for melanoma recurrence after negative sentinel node biopsy in middle-aged and older men","volume":"38","author":"Kaveh","year":"2016","journal-title":"Head\u00a0Neck"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104458_bib48","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/cam4.2128","article-title":"Prospective validation of the prognostic 31-gene expression profiling test in primary cutaneous melanoma","volume":"8","author":"Keller","year":"2019","journal-title":"Cancer Med."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104458_bib49","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","article-title":"The eighth edition American joint committee on cancer (AJCC) melanoma staging system: implications for melanoma treatment and care","volume":"18","author":"Keung","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104458_bib50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00403-021-02229-8","article-title":"Risk factors and patterns of recurrence after sentinel lymph node biopsy for thin melanoma","volume":"314","author":"Kim","year":"2022","journal-title":"Arch. Dermatol. Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104458_bib51","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1038\/s41591-023-02583-2","article-title":"Adjuvant nivolumab in resected stage IIB\/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial","volume":"29","author":"Kirkwood","year":"2023","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104458_bib52","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.1984.2.9.994","article-title":"Lentigo maligna melanoma has no better prognosis than other types of melanoma","volume":"2","author":"Koh","year":"1984","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104458_bib53","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1158\/1078-0432.CCR-1161-03","article-title":"T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma","volume":"10","author":"Lad\u00e1nyi","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2024.104458_bib54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.maturitas.2022.10.010","article-title":"The effect of menopausal hormone therapy on the risk of melanoma and keratinocyte skin cancer: a systematic review and meta-analysis of observational studies","volume":"168","author":"Lallas","year":"2023","journal-title":"Maturitas"},{"issue":"10336","key":"10.1016\/j.critrevonc.2024.104458_bib55","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/S0140-6736(22)00562-1","article-title":"Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial","volume":"399","author":"Luke","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104458_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086194","article-title":"Survival according to BRAF-V600 tumor mutations--an analysis of 437 patients with primary melanoma","volume":"9","author":"Meckbach","year":"2014","journal-title":"PLOS One"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104458_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032955","article-title":"Time course and pattern of metastasis of cutaneous melanoma differ between men and women","volume":"7","author":"Mervic","year":"2012","journal-title":"PLOS One"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104458_bib58","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10585-012-9476-2","article-title":"CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma","volume":"29","author":"Monteagudo","year":"2012","journal-title":"Clin. Exp. Metastasis"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104458_bib59","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1245\/s10434-007-9675-2","article-title":"Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy","volume":"15","author":"Morris","year":"2008","journal-title":"Ann. Surg. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104458_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122854","article-title":"Using a clinicopathologic and gene expression (CP-GEP) model to identify stage I-II melanoma patients at risk of disease relapse","volume":"14","author":"Mulder","year":"2022","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104458_bib61","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/0284186X.2020.1747636","article-title":"BRAF mutational status as a prognostic marker for survival in malignant melanoma: a systematic review and meta-analysis","volume":"59","author":"Ny","year":"2020","journal-title":"Acta Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104458_bib62","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jaad.2019.09.029","article-title":"Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populations","volume":"83","author":"Oh","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104458_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14041060","article-title":"Using a 31-gene expression profile test to stratify patients with stage I-II cutaneous melanoma according to recurrence risk: update to a prospective, multicenter study","volume":"14","author":"Podlipnik","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2024.104458_bib64","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jss.2020.11.058","article-title":"Predictors of nonsentinel lymph node metastasis in cutaneous melanoma: a systematic review and meta-analysis","volume":"260","author":"Rajaee","year":"2021","journal-title":"J. Surg. Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104458_bib65","doi-asserted-by":"crossref","first-page":"T413","DOI":"10.1016\/j.ad.2023.04.023","article-title":"Update on lentigo maligna: diagnostic signs and treatment","volume":"114","author":"Requena","year":"2023","journal-title":"Actas Dermo-Sifiliogr. \u00e1ficas"},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104458_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122902","article-title":"Identifying high-risk tumors within AJCC stage IB-III melanomas using a seven-marker immunohistochemical signature","volume":"13","author":"Reschke","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104458_bib67","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/bjd.12586","article-title":"Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients","volume":"169","author":"Ribero","year":"2013","journal-title":"Br. J. Dermatol."},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104458_bib68","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/PAS.0b013e31822573f5","article-title":"Clinical relevance of detection of lymphovascular invasion in primary melanoma using endothelial markers D2-40 and CD34","volume":"35","author":"Rose","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104458_bib69","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.jaad.2020.08.108","article-title":"Risk factors affecting the first metastasis of acral melanoma: low- pigmentation independently predicts a first lung metastasis","volume":"84","author":"Ryu","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104458_bib70","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/ijc.33479","article-title":"Skin melanoma deaths within 1 or 3\u2009years from diagnosis in Europe","volume":"148","author":"Sacchetto","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104458_bib71","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3892\/or.2014.3265","article-title":"Younger age at the time of first metastasis in BRAF-mutated compared to BRAF wild-type melanoma patients","volume":"32","author":"Saint-Jean","year":"2014","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104458_bib72","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1038\/s41598-020-61637-4","article-title":"Transcriptomic identification of miR-205 target genes potentially involved in metastasis and survival of cutaneous malignant melanoma","volume":"10","author":"S\u00e1nchez-Sendra","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104458_bib73","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/CMR.0000000000000093","article-title":"Prognostic differences across sexes in melanoma patients: what has changed from the past?","volume":"24","author":"Sanlorenzo","year":"2014","journal-title":"Melanoma Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104458_bib74","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1468-3083.2011.04055.x","article-title":"Disease progression in melanoma patients with negative sentinel lymph node: does false-negative specimens entirely account for this phenomenon?","volume":"26","author":"Savoia","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104458_bib75","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/jamadermatol.2019.0440","article-title":"Risk of melanoma recurrence after diagnosis of a high-risk primary tumor","volume":"155","author":"von Schuckmann","year":"2019","journal-title":"JAMA Dermatol."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104458_bib76","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1038\/jid.2014.85","article-title":"Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable disease","volume":"134","author":"Sivendran","year":"2014","journal-title":"J. Investig. Dermatol."},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104458_bib77","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/1097-0142(20010601)91:11<2110::AID-CNCR1239>3.0.CO;2-Q","article-title":"A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma","volume":"91","author":"Starz","year":"2001","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.critrevonc.2024.104458_bib78","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104458_bib79","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jso.26678","article-title":"Regression in melanoma is significantly associated with a lower regional recurrence rate and better recurrence-free survival","volume":"125","author":"Subramanian","year":"2022","journal-title":"J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104458_bib80","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaoncol.2015.0493","article-title":"Association between NRAS and BRAF mutational status and melanoma-specific survival among patients with higher-risk primary melanoma","volume":"1","author":"Thomas","year":"2015","journal-title":"JAMA Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104458_bib81","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1245\/s10434-019-07369-w","article-title":"Recurrence of melanoma after a negative sentinel node biopsy: predictors and impact of recurrence site on survival","volume":"26","author":"Thomas","year":"2019","journal-title":"Ann. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104458_bib82","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jaad.2021.10.062","article-title":"Development and validation of a nomogram incorporating gene expression profiling and clinical factors for accurate prediction of metastasis in patients with cutaneous melanoma following Mohs micrographic surgery","volume":"86","author":"Thorpe","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"24","key":"10.1016\/j.critrevonc.2024.104458_bib83","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1056\/NEJMoa2200075","article-title":"Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer","volume":"386","author":"Tie","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2024.104458_bib84","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.critrevonc.2024.104458_bib85","first-page":"2301020","article-title":"Predicting recurrence-free and overall survival for patients with stage II melanoma: the MIA calculator","author":"Varey","year":"2024","journal-title":"J. Clin. Oncol., Jco"},{"key":"10.1016\/j.critrevonc.2024.104458_bib86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejca.2020.04.022","article-title":"The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node\u2013positive melanoma without the need for completion lymph node dissection","volume":"134","author":"Verver","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104458_bib87","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaad.2023.11.040","volume":"90","author":"Wagner","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104458_bib88","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jaad.2023.08.105","article-title":"Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma","volume":"90","author":"Wan","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.critrevonc.2024.104458_bib89","unstructured":"Wells, G.A., Wells, G., Shea, B., Shea, B., O'Connell, D., Peterson, J., Welch, Losos, M., Tugwell, P., Ga, S.W., Zello, G.A., Petersen, J.A., 2014. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104458_bib90","first-page":"23","article-title":"Gene expression profiling of primary cutaneous melanoma","volume":"69","author":"Winnepenninckx","year":"2007","journal-title":"Verh. K. Acad. Geneeskd. Belg."},{"key":"10.1016\/j.critrevonc.2024.104458_bib91","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-62703-727-3_15","article-title":"Lymphatic invasion as a prognostic biomarker in primary cutaneous melanoma","volume":"1102","author":"Xu","year":"2014","journal-title":"Methods Mol. Biol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824002014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824002014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:13:13Z","timestamp":1725495193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842824002014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":91,"alternative-id":["S1040842824002014"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104458","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, dermatoscopic, histological and molecular predictive factors of distant melanoma metastasis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104458"}}